Vergoeding 2018-2022 voor ATC-subgroep J01 : Antibacteriele middelen voor systemisch gebruik
- Raming voor de totale Zvw-populatie
| 2018 | 2019 | 2020 | 2021 | 2022 | |
|---|---|---|---|---|---|
| J01A Tetracyclines | 2.767.100 | 2.619.200 | 2.486.500 | 3.904.100 | 5.199.600 |
| J01B Amfenicolen | . | 10 | . | . | 11 |
| J01C Betalactam-antibiotica penicillines | 8.621.600 | 10.348.300 | 11.390.700 | 13.651.700 | 16.722.500 |
| J01D Overige betalactam-antibiotica | 4.706.300 | 5.367.300 | 5.532.300 | 6.000.400 | 6.841.400 |
| J01E Sulfonamiden en trimethoprim | 1.071.000 | 1.331.300 | 1.369.300 | 1.410.800 | 1.502.000 |
| J01F Macroliden lincosamiden en streptograminen | 4.015.100 | 4.777.100 | 4.242.800 | 3.167.100 | 3.624.100 |
| J01G Aminoglycosiden | 4.486.000 | 4.384.200 | 4.163.300 | 4.165.800 | 3.860.600 |
| J01M Chinolonen | 2.150.700 | 2.315.300 | 2.418.500 | 2.358.500 | 2.369.400 |
| J01X Overige antibacteriele middelen | 9.629.300 | 10.072.800 | 10.455.100 | 10.836.600 | 10.758.800 |
| Totaal | 37.447.100 | 41.215.510 | 42.058.500 | 45.495.000 | 50.878.411 |